LENZ

LENZ Therapeutics, Inc.

Healthcare · Biotechnology

$172.74 sample

-2.59 (-1.48%) 1D

Market cap

$568.9B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-29

Alerts

8

Price$172.74 +6.24% 3M daily closessample

178.57161.56

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: Chief Financial Officer
Oct 06INSInsider sell: EVP, Operations
Sep 29SEC8-K filed: material event
Sep 23INSInsider sell: EVP, Operations
Sep 17INSInsider buy: Chief Executive Officer
Sep 10SECDEF 14A filed
Sep 01INSInsider sell: Chief Financial Officer
Aug 27INSInsider sell: Chief Financial Officer

Sign up to see the real LENZ record →

Company facts

SEC EDGAR registration

Name: LENZ Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +12sample, -100 to +100
Reporting currency: USD

Who is positioning in LENZ

sample

Insiders: 11 insider transactions over 90 days, net selling, $148.4M
Congress: 3 members traded over 90 days
Institutions · 13F: 36 funds hold $13.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$17.8B +18.3% y/y

Q4 2024Q3 2026

Inventory$10.0B +6.2% y/y

Q4 2024Q3 2026

Accounts receivable$7.7B +5.5% y/y

Q4 2024Q3 2026

Total debt$21.1B +17.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $546.0B -4.3% 3M
Sample peer B: $532.1B +3.9% 3M
Sample peer C: $346.5B +10.9% 3M
Sample peer D: $283.7B +9.4% 3M
Sample peer E: $117.6B +8.7% 3M